MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.

MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q38803437
The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma.C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells.Effect of Liver Disease on Hepatic Transporter Expression and Function.Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.PharmGKB summary: sorafenib pathways.Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib.
P2860

MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q38803437
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.
@en
type
label
MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.
@en
prefLabel
MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932